VitroScan

😃 We were honored to welcome Leiden's Mayor Peter Heijkoop to our VitroScan office, as part of his broader tour of the innovative companies Leiden Bio Science Park, this past Friday! His visit provided an exciting opportunity to showcase our mission, technology, and team. We discussed how our technology could reshape treatment decisions by predicting the effectiveness of 💊 drug therapies before a patient even starts treatment! Our lab tour offered a hands-on look at our work, including an opportunity for Mayor Heijkoop to examine microscopic samples 🔬🧫 from a patient with ovarian cancer, alongside our colleague Timothy Sijsenaar. 💪 We're proud to contribute to Leiden's growing reputation as a leader in life sciences and grateful to Mayor Heijkoop for taking the time to learn about our work, our people, and our vision for the future of healthcare! 🙏 📍Read more at https://lnkd.in/eJ5nG_jk #PrecisionMedicine #Exvivotumortesting

💪 Strong biomarkers that identify a patient's response to treatment are crucial for successful introduction of antibody-drug conjugates (ADCs) to the clinic. VitroScan's 👩🔬 Esmee Koedoot presented our poster on ex vivo efficacy of Mirvetuximab in ovarian cancer, supported by target protein expression on patients' tumor tissues. In addition, she presented on the characterization of the tumor microenvironment (TME) to monitor efficacy of immunotherapies. 👏👏👏 VitroScan at the #ENASymp24!   👇 Download our posters here! 📍 "Ex vivo 3D micro-tumor testing platform to guide patient stratification for clinical development of antibody-drug conjugates", in which we show the value of our platform for ADC sensitivity profiling and biomarker development using heterogeneous fresh patient samples. - https://lnkd.in/ecMAxrRV 📍 "Ex vivo patient micro-tumor testing to characterize and predict immunotherapy drug responses", in which classification, characterization and validation of patient-specific sensitivity to immunotherapies in lung cancer and ovarian cancer is explained. - https://lnkd.in/edniTUpv #personalizedmedicine
#exvivotumortesting

We love working together with people that are just as passionate as we are!

😃 We're excited to present our poster 👩🔬 "Characterization of the tumor micro-environment in ex vivo 3D micro tumor assays to discover translational markers for ovarian and lung cancer" at the Festival of Biologics in Basel this week! 🤝 Please come see us there and learn more about how our #exvivotumortesting platform can accurately identify patients that are sensitive to novel biologics! #festivalofbiologics #antibodydrugconjungate #bispecificantibody #patientstratification #oncology

We are always very grateful for patients participating in our trials and joining us to push the boundaries of personalised medicine. 🙏 🧫 Today, we received our first biopsy tissue from a #melanoma patient. Its sensitivity to immunotherapy will be evaluated in a new ex vivo pilot study. 🤝We're excited to collaborate with the expert team at Leiden University Medical Center as well as Ellen Kapiteijn and Els Verdegaal and are looking forward to seeing the results of this study! Leiden Bio Science Park Stichting Melanoom #exvivotumortesting #precisionmedicine

📣 WE'RE HIRING! ✅ Are you a highly motivated molecular biologist? ✅ Do you want to help shape our technology towards reliable in vivo tumor testing? ✅ Do you want to have a broad range of different responsibilities and a high level of autonomy while working in for rapidly developing start-up? Then this may be the perfect time to join our team! 😃 👩🔬 We are seeking a highly motivated and talented (Senior) Scientist with a strong background in cancer biology and the ability to connect assay development in the lab with the data science platform. 🧪 The (Senior) Scientist will be executing the ex vivo drug testing program in the context of ongoing clinical trials and further shape the development of our technology towards robust and reliable testing according to high (clinical) quality standards. See 📍https://lnkd.in/ee9jqHNt!

📣 WE'RE HIRING! ✅ Are you a highly motivated molecular biologist? ✅ Do you want to help shape our technology towards reliable in vivo tumor testing? ✅ Do you want to have a broad range of different responsibilities and a high level of autonomy while working in for rapidly developing start-up? Then this may be the perfect time to join our team! 😃 👩🔬 We are seeking a highly motivated and talented (Senior) Scientist with a strong background in cancer biology and the ability to connect assay development in the lab with the data science platform. 🧪 The (Senior) Scientist will be executing the ex vivo drug testing program in the context of ongoing clinical trials and further shape the development of our technology towards robust and reliable testing according to high (clinical) quality standards. See 📍https://lnkd.in/ee9jqHNt!

We are excited to announce the launch of a brand-new purchasing program with Merck Group! Hollandbio members can now save on thousands of Merck Life Science products tailored to the biotech research workflow. 🔬 Access to discounts up to 60% on over 2400 Merck Life Science products  🔬  Solutions for Analytical & Synthetic Chemistry, mRNA, mAbs, Peptide Synthesis, Microbiology, Cell Culture, Molecular Biology, Protein Workflows, Immuno Assays and more. Join the hollandbio – Merck purchasing program and start saving!  Check all our partner offers here 🔗 https://lnkd.in/eRqKCg99    #biotech #lifescience #labequipment #workflow 

🤝 Meet our colleague Lieke Ceton - Scientist Bioinformatics. “Preparing our data so that we can test biological hypotheses is a creative process and I love collaborating with our lab scientists so that we can translate the data to powerful insights!” This week, Lieke is busy 👩🔬 analyzing immune data for our presentation at the EORTC-NCI-AACR Symposium, where we will be sharing insights of the tumor microenvironment in relation to clinical biomarkers and the tumor's ex vivo sensitivity to immune checkpoint inhibitors. #ENAsymp24 #exvivotumortesting #personalizedmedicine #meetourcolleague

Willemijn Vader is sharing our predictive testing capabilities to sync with the needs in the field of oncology. See you there!